Page last updated: 2024-09-04

levofloxacin and Anthrax

levofloxacin has been researched along with Anthrax in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (23.53)29.6817
2010's10 (58.82)24.3611
2020's3 (17.65)2.80

Authors

AuthorsStudies
Bower, WA; Bulitta, JB; Chatham-Stephens, K; Cook, R; Hendricks, K; Kennedy, JL; Mongkolrattanothai, T; Negron, ME; Person, MK; Shin, E; Yu, P1
Crumrine, M; Hewitt, JA; Slay, RM1
Alameh, S; Amali-Adekwu, E; Bartolo, G; Beasley, DWC; Bradley, KA; Cheng, LW; Chugunova, M; Cote, CK; Demons, ST; Derbedrossian, A; Fetterer, DP; Halasahoris, SA; Hartmann, S; Ho, CC; Kao, CY; Klimko, CP; Lawrence, WS; Levitin, A; Martchenko Shilman, M; McComb, R; Miller, LL; Peel, JE; Peterson, JW; Shoe, JL; Sivasubramani, SK; Tran, JK; West, J; Zilbermintz, L1
Carpenter, S; Henning, LN; Serbina, NV; Stark, GV1
Xie, H; Yuan, HL; Zhang, W; Zheng, YY1
Bar-David, E; Ben-Shmuel, A; Brosh, T; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S1
Comer, J; Kammanadiminti, S; Kodihalli, S; Meister, G; Patnaikuni, RK; Sinclair, C1
Bolmer, S; Buccellato, M; Corey, A; Meister, G; Migone, TS; Vasconcelos, D; Zhong, J1
Head, BM; Meyers, AF; Rubinstein, E1
Chien, S; Li, F; Nandy, P; Noel, GJ; Tornoe, CW1
Dyer, DN; Hatkin, JM; Orr, SA; Pitt, ML; Yee, SB1
Bourdage, JS; Duchars, M; Fuerst, TR; Fusco, PC; Leffel, EK; Williamson, ED1
Bolmer, S; Chen, C; Corey, A; Fiscella, M; Meister, G; Migone, TS; Ward, C1
De Vecchi, E; Drago, L; Gismondo, MR; Lombardi, A; Nicola, L; Valli, M1
Doganay, M; Esel, D; Sumerkan, B1
Basset, J; Bush, K; Byrne, WR; Deziel, MR; Drusano, GL; Heine, H; Kao, M; Kelly, M; Louie, A; Miller, L1
Barnewall, R; Bush, K; Chien, S; Drusano, GL; Estep, J; Hemeryck, A; Kao, LM; Kelley, MF; Minton, N; Olson, PH; Thalacker, FW1

Reviews

2 review(s) available for levofloxacin and Anthrax

ArticleYear
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactams; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Doxycycline; Glycopeptides; Humans; Levofloxacin; Lipopeptides; Models, Animal; Tetracyclines; United States

2022
Alternative pre-approved and novel therapies for the treatment of anthrax.
    BMC infectious diseases, 2016, Nov-03, Volume: 16, Issue:1

    Topics: Alpha-Globulins; Anthrax; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Daunorubicin; DNA Helicases; Doxorubicin; Drug Discovery; Fluoroquinolones; Humans; Interferon Inducers; Levofloxacin; Linezolid; Moxifloxacin; Ofloxacin; Polyketides; Serine Proteinase Inhibitors; Tilorone; Virulence

2016

Trials

1 trial(s) available for levofloxacin and Anthrax

ArticleYear
Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Adolescent; Aging; Anthrax; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Body Weight; Child; Child, Preschool; Chromatography, High Pressure Liquid; Double-Blind Method; Female; Humans; Infant; Inhalation Exposure; Injections, Intravenous; Kidney Function Tests; Levofloxacin; Male; Ofloxacin; Spores, Bacterial; Tablets

2010

Other Studies

14 other study(ies) available for levofloxacin and Anthrax

ArticleYear
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Azithromycin; Bacillus anthracis; Clarithromycin; Disease Models, Animal; Levofloxacin; Macaca fascicularis; Respiratory Tract Infections

2022
    ACS infectious diseases, 2021, 08-13, Volume: 7, Issue:8

    Topics: Amodiaquine; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Levofloxacin; Mice; Rabbits; Systematic Reviews as Topic

2021
Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Drug Therapy, Combination; Female; Immunization, Passive; Immunoglobulin G; Immunologic Memory; Levofloxacin; Male; Rabbits; Random Allocation; Respiratory Tract Infections; Spores, Bacterial; Survival Analysis

2018
Two cases of human cutaneous anthrax with massive tissue damage, severe edema, and slight injury to the liver.
    International journal of dermatology, 2018, Volume: 57, Issue:3

    Topics: Adult; Anthrax; Biopsy, Needle; Blister; Drug Therapy, Combination; Edema; Humans; Immunohistochemistry; Levofloxacin; Liver; Male; Methylprednisolone; Middle Aged; Penicillin G; Prognosis; Risk Assessment; Skin Diseases, Bacterial; Soft Tissue Injuries; Treatment Outcome; Upper Extremity

2018
Treating Anthrax-Induced Meningitis in Rabbits.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Antitoxins; Bacillus anthracis; Central Nervous System; Ciprofloxacin; Clindamycin; Dexamethasone; Disease Models, Animal; Drug Combinations; Imipenem; Levofloxacin; Linezolid; Meningitis, Bacterial; Meropenem; Rabbits; Treatment Failure

2018
Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins, Intravenous; Levofloxacin; Male; Rabbits; Respiratory Tract Infections; Toxemia; Treatment Outcome

2014
Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Levofloxacin; Male; Rabbits; Respiratory Tract Infections

2015
Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Comparative medicine, 2010, Volume: 60, Issue:6

    Topics: Aerosols; Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Biomarkers; Female; Levofloxacin; Male; Ofloxacin; Rabbits; Spores, Bacterial; Time Factors

2010
Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Clinical and vaccine immunology : CVI, 2012, Volume: 19, Issue:8

    Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antigens, Bacterial; Bacterial Toxins; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunoglobulin G; Levofloxacin; Ofloxacin; Post-Exposure Prophylaxis; Rabbits; Recombinant Proteins; Respiratory Tract Infections; Survival Analysis; Treatment Outcome; Vaccination

2012
Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Toxins, 2013, Jan-14, Volume: 5, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Inhalation; Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Disease Models, Animal; Female; Kinetics; Levofloxacin; Male; Ofloxacin; Rabbits; Spores, Bacterial; Survival Analysis

2013
Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:6

    Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Penicillins; Thienamycins

2002
Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.
    International journal of antimicrobial agents, 2003, Volume: 22, Issue:1

    Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin G; Penicillins; Turkey

2003
Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Animals; Anthrax; Anti-Infective Agents; Bacillus anthracis; Humans; Levofloxacin; Macaca mulatta; Mice; Ofloxacin; Preventive Medicine

2005
Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11

    Topics: Aerosols; Animals; Anthrax; Anti-Bacterial Agents; Area Under Curve; Bacillus anthracis; Computer Simulation; Dose-Response Relationship, Drug; Drug Compounding; Female; Humans; Inhalation Exposure; Levofloxacin; Macaca mulatta; Male; Microbial Sensitivity Tests; Ofloxacin; Spores, Bacterial

2006